GMIPulse - 医疗保健市场情报订阅

Global Market Insights Inc. 提供 GMIPulse，这是一个支援商业智慧 (BI) 的尖端平台，旨在提供最佳的策略价值。 GMIPulse 提供适应性强的订阅服务，可根据您的独特需求进行客製化，提供全面而细緻的市场资料、竞争格局洞察以及对行业生态系统的深入了解。该平台是满足所有市场研究需求的首选解决方案，确保您保持领先地位，并了解最新趋势和技术进步。

GMI脉衝的优点

• 1. 轻鬆取得准确的市场数据：GMIPulse 可即时取得细緻、真实的市场资料，为您提供准确、最新的策略决策资讯。
• 2. 全面的市场研究解决方案：GMIPulse作为您全方位的市场研究工具，涵盖广泛的行业，提供详细的分析和预测，帮助您有效驾驭市场动态。
• 3. 深度竞争格局：平台提供全面的竞争格局和公司概况洞察，让您全面了解竞争对手和产业标竿。
• 4.了解产业生态系统：GMIPulse让您深入了解产业生态系统，追踪技术进步及其对产业趋势的影响。
• 5. 客製化客户檔案：量身订製的客户檔案可协助您识别最新的成长机会并了解特定的市场需求，从而增强您的策略规划。
• 6. 技术追踪 随时了解最新的技术趋势及其对市场的影响，确保您为未来的发展做好充分准备。
• 7. 存取最新报告：订阅者可以存取先前发布的报告和即将发布的报告，让您随时了解最新的市场情报。
• 8. 互动式且使用者友善的介面：此平台的互动式介面可确保无缝的使用者体验，让您轻鬆浏览资料并有效地获得有意义的见解。
• 9. 延长分析师工作时间：受益于更好地获得分析师的策略帮助和深入解释，确保您做出明智的决策。
• 10. 安全登入：所有报告均受密码保护，确保您的资料安全保密。

GMIPulse 的卓越优势

• 1. 即时存取报告：GMIPulse 为客户提供即时存取全面市场报告的直接存取权限，协助客户及时做出明智的决策。
• 2. GMI Pulse 隆重推出 MyraAI 辅助功能：这项突破性功能让每个人都能以任何语言取得资料洞察。 MyraAI 支援多语言，可无缝翻译复杂的报告并即时解答疑问。
• 3. 互动式仪錶板：所有 GMI Pulse 使用者均可使用互动式仪錶板，彻底改变您与资料互动的方式。您可以轻鬆按地区、细分市场等筛选数据，从而专注于最重要的事项。简洁的介面让您即使没有技术技能也能轻鬆调整，即时更新功能能让您随时随地获得洞察。
• 4. 客製化报告：存取由行业领袖根据您的需求量身定制的详细市场趋势、技术发展和创新报告。
• 5. 优先销售支援：提供快速、一流的销售支援与协助，提升客户服务体验。
• 6. 市场追踪：有效率取得所有市场趋势和动态，随时了解最新动态，为策略规划和决策提供参考。
• 7. 价格优势：全面、经济高效的报告，满足您的预算和需求。

产业聚焦：医疗保健

在技​​术进步、监管变化以及对创新治疗和服务的需求不断成长的推动下，医疗保健行业正在经历快速转型。 GMIPulse 提供对医疗保健产业内以下关键集群的深入见解：

分析仪器

在对先进诊断工具和研究应用的需求不断成长的推动下，分析仪器市场预计从 2023 年到 2030 年将以 6.5% 的复合年成长率成长。关键部分包括色谱法、光谱学和分子分析。精准医学和基因组学的兴起极大地推动了对高精度分析仪器的需求。

生物技术

在基因工程、生物製药以及细胞和基因疗法进步的推动下，生物技术市场预计从 2023 年到 2030 年将以 7.8% 的复合年成长率强劲扩张。主要市场包括基因组学、蛋白质组学和生物加工。 CRISPR技术和个人化医疗的出现是推动市场成长的关键驱动力。

药械组合

在慢性病盛行率不断上升以及对创新药物输送系统的需求的推动下，药物器材组合市场预计从 2023 年到 2030 年将以 8.1% 的复合年成长率成长。主要例子包括药物洗脱支架、经皮贴片和吸入器。智慧技术在药物设备组合中的整合正在提高患者的依从性和治疗效果。

医疗保健资讯技术

在电子健康记录 (EHR)、远距医疗和健康资讯交换 (HIE) 日益普及的推动下，医疗保健 IT 市场预计从 2023 年到 2030 年将以 9.4% 的复合年成长率扩张。关键领域包括临床资讯学、医疗保健分析和网路安全。向基于价值的护理的转变和对互通性的需求是推动市场的重要趋势。

医疗设备

在技​​术进步和人口老化的推动下，医疗器材市场预计从 2023 年到 2030 年将以 5.9% 的复合年成长率成长。主要领域包括诊断影像、手术器械和穿戴式装置。人工智慧驱动的诊断工具和微创手术设备等创新正在改变患者护理。

医疗服务

在专业医疗服务和家庭医疗保健需求不断成长的支持下，医疗服务市场预计从 2023 年到 2030 年将以 6.2% 的复合年成长率扩张。关键领域包括远距医疗、门诊护理和復健服务。对预防保健和慢性病管理的日益关注正在重塑医疗服务格局。

药品

在创新药物需求不断成长以及生物製剂和生物学名药兴起的推动下，预计 2023 年至 2030 年药品市场将以 6.8% 的复合年成长率成长。主要市场包括肿瘤学、免疫学和罕见疾病。新疗法和精准医学的发展是影响市场成长的主要趋势。

Global Market Insights Inc. 的 GMIPulse 透过其支援 BI 的平台提供无与伦比的策略价值。凭藉其可自订的互动式介面、准确的资料和全面的市场洞察，GMIPulse 是您在竞争激烈的医疗保健市场中保持领先地位的重要工具。立即订阅，释放您的市场研究和策略规划能力的全部潜力。

Global Market Insights Inc. offers GMIPulse, a cutting-edge, Business Intelligence (BI)-enabled platform designed to deliver the finest strategic value. GMIPulse offers an adaptable subscription service, customizable to meet your unique needs, providing comprehensive and granular market data, competitive landscape insights, and an in-depth understanding of industry ecosystems. This platform is your go-to solution for all market research needs, ensuring you stay ahead with the latest trends and technological advancements.

Advantages of GMIPulse

• 1. Easy Access to Accurate Market Data: GMIPulse provides instant access to granular and authentic market data, empowering you with precise and up-to-date information for strategic decision-making.
• 2. Comprehensive Market Research Solution: As your all-encompassing market research tool, GMIPulse covers a wide array of industries, offering detailed analyses and forecasts to help you navigate market dynamics effectively.
• 3. In-Depth Competitive Landscape: The platform offers comprehensive insights into competitive landscapes and company profiles, enabling you to understand your competitors and industry benchmarks thoroughly.
• 4. Understanding Industry Ecosystems: GMIPulse allows you to gain a profound understanding of industry ecosystems, tracking technological advancements and their impact on industry trends.
• 5. Customized Client Profiles: Tailor-made client profiles help you identify the latest growth opportunities and understand specific market needs, enhancing your strategic planning.
• 6. Technology Tracking Stay informed about the latest technological trends and their implications on the market, ensuring you are well-prepared for future developments.
• 7. Access to Latest Reports: Subscribers receive access to previously published reports and upcoming releases, keeping you updated with the most recent market intelligence.
• 8. Interactive and User-Friendly Interface: The platform's interactive interface ensures a seamless user experience, allowing you to navigate through data effortlessly and derive meaningful insights efficiently.
• 9. Enhanced Analyst Hours: Benefit from improved access to analysts for strategic assistance and in-depth explanations, ensuring you make well-informed decisions.
• 10. Secure Login: Enjoy password-protected access to all reports, ensuring your data security and confidentiality.

Exceptional Benefits of GMIPulse

• 1. Instant Report Access GMIPulse offers clients direct access to comprehensive market reports instantly, facilitating timely and informed decision-making.
• 2. MyraAI, Introducing MyraAI Assistance within GMI Pulse: a game-changing feature that makes data insights accessible to everyone, in any language. With multilingual support, MyraAI seamlessly translates complex reports and answers your questions in real-time, breaking down language barriers for effortless, intuitive data exploration.
• 3. Interactive Dashboard We're excited to announce that the Interactive Dashboard is now available to all GMI Pulse users, changing the way you interact with your data. With easy data filtering by region, segment, and more, you can focus on what matters most. The simple interface lets you make adjustments without technical skills, and real-time updates provide live insights as you work.
• 4. Tailor-Made Reports Access customized reports detailing market trends, technological developments, and innovations by industry leaders, tailored to your specific needs.
• 5. Priority Sales Support Receive best-in-class sales support and assistance promptly, enhancing your customer service experience.
• 6. Market Tracker Stay updated with streamlined access to all market trends and happenings, aiding in strategic planning and decision-making.
• 7. Pricing Benefits Obtain reports that are not only comprehensive but also cost-effective, tailored to fit your budget and needs.

Industry Focus: Healthcare

The healthcare industry is undergoing rapid transformation driven by technological advancements, regulatory changes, and increasing demand for innovative treatments and services. GMIPulse provides in-depth insights into the following key clusters within the healthcare industry:

Analytical Instruments

The global analytical instruments market provides a critical scientific discovery tool and a QA and regulatory platform in all industries. The increase in advancement in technology, enhanced agency, and private sector R&D spending, and further utilization in pharmaceuticals, biopharmaceuticals, monitoring of health, and monitoring of the environment contributed to an observable upward trend.

The total market value for analytical instruments was reasonable valuations by 2024, with the market pricing trajectory indicating an observable compound annual growth rate (CAGR) between 2025-2034. This larger market contains several subcategories, such as chromatography, elemental analysis, immunoassay, supplies and laboratory equipment, microscopy, molecular analysis, and spectroscopy for vital analytical work in research institutions, clinical laboratories, and industrial quality control activities.. The molecular analysis segment is attractive for well-established growth opportunities from utilization patterns of increasingly high-throughput and precision methodologies in diagnostics and research.

The spectroscopy category is impressive from multiple technologies and different segments, whereas the USD 4 billion molecular spectroscopy category in 2023 is expected to exceed an estimated CAGR of 6% during 2024-2032, with specialized markets such as the USD 1.3 billion IR spectroscopy category in 2023 possibly expecting a 5% CAGR during the period 2024-2032. The sophisticated analytical methods utilize advancements in next-generation sequencing, polymerase chain reaction, and mass spectrometry to improve research capability and diagnostic accuracy.

The primary drivers of the market include increasing spending on R&D in the pharmaceutical industry, strict compliance with regulations, integration via artificial intelligence and automation, and expanding applications in clinical diagnostics and environmental testing. The industry is being enabled by miniaturization trends, greater sensitivity and accuracy of analyzers, and increasing demand for portable and point-of-care analytical solutions. Emerging manufacturing technologies, digitalization, and intelligent laboratory designs continue to transform analytical procedures and operational efficiency in all analytical instrument subcategories.

Biotechnology

The global biotechnology industry is one of the most agile and fastest-growing sectors in modern science and medicine, fueled by advancements in genetic engineering, personalized medicine, and novel therapeutics. India's biotech industry, as reported by Invest India, is fast emerging as one of the prime drivers of economic and technological progress, and it contributes approximately 4% to the world's biotech market, with exemplary capabilities in agricultural biotechnology, biopharmaceuticals, and vaccines.

This broad market covers key subcategories such as biopharmaceuticals, bioservices, and biotechnology R&D, each covering necessary segments of scientific innovation, therapeutic development, and commercial biotechnology applications in various industries like healthcare, agriculture, and industrial biotechnology. The biopharmaceutical segment shows outstanding growth prospects with the total biopharmaceutical market worldwide pegged at USD 422.5 billion in 2024, growing from USD 453.7 billion in 2025 to USD 921.5 billion in 2034 at a CAGR of 8.2%, fueled by rising demands for targeted therapies and biologics.

Support for biotechnology R&D infrastructure shows remarkable momentum. The bioreactors market was valued at USD 10.4 billion in 2023 and will grow at 11.8% CAGR from 2024 to 2032, while the contract research organization (CRO) market will reach USD 59.8 billion in 2023 and expand at 8.1% CAGR from 2024 to 2032, supported by increasing public and private R&D spending worldwide. Each of these niches illustrates the commitment of this sector to improved scientific discovery and therapeutic development.

Growth drivers include aging populations worldwide, the rising prevalence of chronic disease, government incentives for new therapies, and significant venture capital funding into biotechnology. The industry enjoys the benefits of cutting-edge manufacturing tools, trends toward personalized medicine, and pro forma collaborations between biotech firms and large pharmaceutical companies. Gene editing, cell therapies, artificial intelligence integration, and precision medicine advances continue to transform therapeutic research and commercial biotechnology products in all biotechnology submarkets.

Drug Device Combination

The global drug device combination products market is a groundbreaking union of pharmaceutical and medical device technologies, with exceptional growth fueled by rising demand for minimally invasive techniques, improved patient outcomes, and technological advancements that merge drug delivery with medical devices. The international drug device combination products market is expected to have robust growth during the next several years. It is a dynamic market that involves key subcategories like drug coated devices, drug filled devices, and therapeutic systems, each serving unique therapeutic applications in the cardiovascular, oncology, and other specialty medical procedures.

Support therapeutic systems have immense growth prospects, with the smart drug delivery systems market valued at USD 10.5 billion in 2023, which is poised to rise from USD 12 billion in 2024 to USD 48.3 billion by 2034 at a CAGR of 17%, led by increased uptake of digital health technologies. The transdermal drug delivery system market reached USD 29 billion in sales in 2022 and is expected to observe 8% CAGR from 2023 to 2032 due to a spectacular increase in cases of chronic diseases.

The major market drivers are the growing incidence of chronic disease, regulatory favor for innovative combination products, technological convergence by nanotechnology and smart materials, and growing preference for patient-focused treatment options. The industry is aided by improved therapeutic effectiveness, better patient compliance, and fewer side effects in comparison to conventional drug delivery systems. Innovative production processes, trends in personalized medicine, and collaborative business strategies between pharmaceutical firms and medical device makers continue to fuel innovation in all subcategories of drug device combinations.

Healthcare IT

The global healthcare IT market is a disruptive force in modern healthcare delivery, and it will continue to achieve unconstrained growth due to digital transformation, a requirement for interoperability, and increasing demand for data-driven healthcare solutions. The aggregate effect of AI, traditional machine learning, and deep learning can entail a total cost savings of up to $360 billion in healthcare expenditures. This wide-ranging market includes key subsegments such as artificial intelligence, health services, healthcare outsourcing, payer/provider solutions, surveillance solutions, and telehealth, which each focus on key digital transformation needs across healthcare organizations and patient care delivery systems.

The segment of artificial intelligence showcases high growth prospects in healthcare IT, with the healthcare generative AI valued at USD 1.8 billion in 2023, rising to USD 20.2 billion by the year 2032. Applications of AI cover diagnostic aid, medical imaging, and patient engagement, with the market for AI in patient engagement solutions worth USD 5 billion in 2023 and expanding at 20.1% CAGR from 2024 through 2032. These technologies use machine learning, natural language processing, and predictive analysis to improve clinical decision-making, operational effectiveness, and patient outcomes in various healthcare environments.

Major drivers of the market include regulatory compliance needs, adoption of value-based care, cybersecurity threats, and the increasing focus on patient-centric models of care delivery.

Fast digitalization was highlighted as the challenge expected to impact the global healthcare systems for the better in 2025, reflecting the healthcare sector's continuing transition from outdated systems to new technologies. The sector is currently optimistic with the adoption of cloud computing, interoperability standards, and mobile health solutions that facilitate care coordination, reduce costs, and improve access across all health IT sectors.

Medical Devices

The medical devices market is one of the most innovative and dynamic healthcare sectors, with intense growth fueled by technology development, aging populations, and rising incidence of chronic conditions necessitating advanced medical interventions. The global medical device market is expected to witness steady growth, with worldwide yearly sales set to grow more than 5% annually, reaching nearly USD 800 billion by the year 2030. This has accelerated the demand for advanced devices and data-driven health care services, the prevalence of lifestyle-related diseases, and opportunities in growth markets, mainly in China and India. The cardiovascular devices market has huge upside potential. The global market for cardiovascular devices is expected to reach USD 7.5 billion in 2024 and is projected to grow at a CAGR of 13.5% from 2025-2034 as demand for minimally invasive surgeries continues to grow.

The wearable medical devices market demonstrates outstanding growth, with the market value at USD 120.1 billion in 2024 and is anticipated to rise to USD 543.9 billion by 2034, with a CAGR of 16.5% over the forecast period. The highly developed healthcare devices make use of technology for real-time monitoring, diagnostics, and treatment purposes in various specialties in medicine. Major market drivers are aging population transitions in demographics, rising incidence of chronic diseases, technology assimilation in the form of IoT and AI functions, and growing healthcare infrastructure in developing economies. The industry is supported by regulatory convergence, adoption of digital health, personalized medicine shifts, and value-based healthcare models driven by enhanced patient outcomes. Materials science innovation, miniaturization technologies, and connectivity solutions continue to transform device capabilities and patient accessibility in all medical device subcategories.

Medical Services

The global medical services sector is a fundamental pillar to the healthcare infrastructure and is currently going through unprecedented growth driven by ageing populations, advancing technological capabilities, and increased demand for comprehensive patient care within the frameworks of a vast array of service delivery models. Healthcare profit pools are increase at 4% CAGR from $654 billion in 2021 to $790 billion by 2026. This growth will be substantially driven by an increased shift toward Medicare as the over-65 population is projected to rise by 3% annually over the forecast period. This large market covers key subcategories, such as diagnostic services, inpatient and outpatient services, laboratory services, long-term care services, and surgical services, each capturing key healthcare delivery needs across a range of patient populations and care settings.

The diagnostic services segment exhibits good growth momentum, and it is reported that specialty areas are experiencing incredible growth. The market for ophthalmology diagnostics had an estimated size of USD 8.7 billion in 2022 and is anticipated to see a CAGR of 4.4% between 2023 and 2032 attributed to the increasing prevalence of eye diseases. Laboratory services continue to be the backbone diagnostic of healthcare system, pathology laboratory equipment market size was USD 33 billion in 2022 and is projected to be USD 75 billion by 2032 due to the increasing incidence of chronic disease. Complementing diagnostic features, the diagnostics segment of the medical display market accounted for USD 2.2 billion revenue in 2022 due to the central position played by it in healthcare wherein proper diagnosis is imperative for patient treatment.

Major drivers in the market are demographic trends to aging populations, rising chronic disease burden, technology integration in the form of digital health solutions, and growing healthcare access in emerging markets. The industry is aided by telemedicine implementation, AI-based diagnostic solutions, and value-based care platforms focusing on patient outcomes. Regulatory compliance, quality standards and health workforce development remains critical to optimize service delivery in all medical service sub-designate.

Pharmaceuticals

The global pharmaceuticals business is one of the most crucial and fastest-growing healthcare industries, fueled by aging populations, rising rates of chronic diseases, and ongoing innovation in drug formulation and manufacturing technology. India's pharmaceutical industry was worth USD 50 billion in FY 2023-24, with USD 23.5 billion representing domestic consumption and USD 26.5 billion in exports, as per government statistics. This large market is comprised of several distinct categories and market segments, including active pharmaceutical ingredients, clinical nutrition, medicines for specific diseases, drug delivery systems, finished drugs, pharmaceutical excipients, manufacturing processes, and vaccines; all of which are critical healthcare and regulatory needs in global markets.

The active pharmaceutical ingredients segment is the backbone of pharmaceutical production, where the market was worth more than USD 228.5 billion in 2022 and is projected to grow at over 6.5% CAGR during the period from 2023 to 2032 due to expanding demand for drugs and treatment of rare diseases. Targeted segments of APIs exhibit impressive growth, such as high potency active pharmaceutical ingredients market worth USD 27.1 billion in 2024 and projected to advance at a 8.8% CAGR during 2025-2034 and small molecule API market worth USD 194.7 billion in 2024 and projected to advance at a 5.8% CAGR during 2025-2034, with escalating incidence of chronic diseases.

Major drivers for the market are increasing healthcare spending, regulatory convergence globally, patent losses giving rise to generic opportunities, and technological innovation in precision medicine, biologics, and personalized therapeutics. The overall sector benefits from substantial research and development investment, continued growth in contract manufacturing, and expanded market access in growing emerging economies. The digitization of the sector and the incorporation of AI-assisted drug discovery and next generation manufacturing technologies are fundamentally changing the efficacy and efficiency of the development, manufacturing, and regulatory compliance of ALL categories and market segments in pharmaceutical development and manufacturing.

GMIPulse by Global Market Insights Inc. offers unparalleled strategic value through its BI-enabled platform. With its customizable and interactive interface, accurate data, and comprehensive market insights, GMIPulse is your essential tool for staying ahead in the competitive healthcare market landscape. Subscribe today to unlock the full potential of your market research and strategic planning capabilities.